503b pharmacy tirzepatide Compounding pharmacies can resume making as FDA reconsiders shortage Compounded Tirzepatide (GLP-1/GIP) Injections |

People who made dosing errors while administering semaglutide from compounding pharmacies have been harmed and even hospitalized after accidentally taking too much, according to an alert issued last week by the FDA

10 Science-Backed Reasonsand Proven Fixes Medical Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment

What Can You Expect From Treatment

This overlap makes baseline IBD control essential before starting GLP-1 therapy and close monitoring during titration critical for distinguishing medication effects from disease activity